Course Exam
301907 VO Development of novel cancer immunotherapies (2019W)
from target identification through target validation to clinical trials
Labels
WHEN?
Friday
17.01.2020
SR 1 - 9.00 Uhr
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Tu 01.10.2019 09:00 to Th 16.01.2020 09:00
- Deregistration possible until Th 16.01.2020 09:00
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: We 19.08.2020 07:49